COVID-19

Dyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine CandidateDyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine Candidate

Dyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine Candidate

Dosing of patients completed at the end of FebruaryData Safety Monitoring Board conducted analysis of Day 29 data No major…

2 years ago
Nanox Announces $30 Million Registered Direct OfferingNanox Announces $30 Million Registered Direct Offering

Nanox Announces $30 Million Registered Direct Offering

NEVE ILAN, Israel, July 24, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative…

2 years ago
Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively EnrollingPanbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling

Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling

Interim Data Analysis anticipated in Early 2024MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical…

2 years ago
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of DirectorsCabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors

Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors

– Ms. Tomasello created and led global commercial and medical affairs functions at Kite Pharma from pre-launch through its acquisition…

2 years ago
Tango Therapeutics Announces First Patient Dosed in TNG260 Phase 1/2 Trial in Patients With STK11-Mutant CancersTango Therapeutics Announces First Patient Dosed in TNG260 Phase 1/2 Trial in Patients With STK11-Mutant Cancers

Tango Therapeutics Announces First Patient Dosed in TNG260 Phase 1/2 Trial in Patients With STK11-Mutant Cancers

BOSTON, July 24, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and…

2 years ago
AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline UpdateAEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update

AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update

Common stock and warrants of combined company will be listed on the New York Stock Exchange American under the symbols…

2 years ago
International Self-Care Day: Better Self-Care, Better Healthcare; Better Welfare GloballyInternational Self-Care Day: Better Self-Care, Better Healthcare; Better Welfare Globally

International Self-Care Day: Better Self-Care, Better Healthcare; Better Welfare Globally

Continued calls for WHO resolution on self-careNYON, SWITZERLAND / ACCESSWIRE / July 24, 2023 / International Self-Care month 2023 opened…

2 years ago
Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private PlacementCosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement

Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement

CHICAGO, IL / ACCESSWIRE / July 21, 2023 / Cosmos Health Inc. (the "Company") (Nasdaq:COSM), a global healthcare group with…

2 years ago